Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)

Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)

ABSTRACT Antiresorptive therapy is the main form of prevention of osteoporotic or fragility fractures. Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but severe adverse reaction to antiresorptive and antiangiogenic drugs. Physicians and dentists caring for patients taking t...

Full description

Bibliographic Details
Main Authors: Miguel Madeira, André Caroli Rocha, Carolina Aguiar Moreira, Águida Maria Menezes Aguiar, Sergio Setsuo Maeda, Abel Silveira Cardoso, Charlles Heldan de Moura Castro, Catarina Brasil D'Alva, Barbara Campolina Carvalho Silva, Bruno Ferraz-de-Souza, Marise Lazaretti-Castro, Francisco Bandeira, Sandra R. Torres
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2020-10-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Osteoporosis
bisphosphonate
medication-related osteonecrosis of the jaw
antifracture therapy
dental care
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600664&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000600664&tlng=en

Similar Items